TRIM29 and myocarditis: Collectively, these data indicate that cardiomyocyte-specific TRIM29 deficiency is sufficient to protect mice from CVB3-induced myocarditis by promoting cardiac antiviral function, attenuating inflammation, reducing cardiac ER stress and apoptosis, and improving cardiac function in vivo.